Prof. Shuanglin Qin | Chemical Biology | Best Researcher Award
Professor at Hunan University of Chinese Medicine , China.
Professor Shuanglin Qin 👨🔬, born on October 1, 1989 🎂, is a prominent researcher at the Research Center for Precision Medication of Chinese Medicine, Hunan University of Chinese Medicine 🏫. With a Ph.D. in Chemical Biology 🎓, his research focuses on anti-cancer drug discovery and traditional Chinese medicinal compounds 💊🌿. Known for his excellence in natural product-based drug development, he has earned notable accolades such as the Hunan Distinguished Young Scholars award 🏅. Prof. Qin also serves as an editorial member for prestigious journals 📚 and actively contributes to advancing chemical biology and precision medicine 🔬✨.
PROFILE
🔍 Summary of Suitability:
Professor Shuanglin Qin demonstrates exceptional research caliber, leadership, and consistent scholarly impact in the fields of chemical biology and anti-cancer drug discovery. His academic journey reflects steady growth from student to professor, with groundbreaking work in natural product-based therapeutics rooted in Traditional Chinese Medicine 🌿. He has earned competitive national and provincial funding, secured editorial roles in top-tier journals, and actively contributed to the peer-review ecosystem of global scientific publications 🌍📚. These achievements mark him as a leader in his field and an ideal candidate for the Best Researcher Award.
🎓 Education & 🧪 Experience
🎓 Education:
-
📍 2016–2019: Ph.D., School of Pharmaceutical Science and Technology, Tianjin University
-
📍 2013–2016: Master’s, School of Pharmacy, Jiangxi Science & Technology Normal University
-
📍 2009–2013: Bachelor’s, School of Pharmacy, Hunan University of Chinese Medicine
🧪 Experience:
-
🧑🏫 2024–2025: Professor, Hunan University of Chinese Medicine
-
🧑🏫 2019–2024: Associate Professor, Hubei University of Science and Technology
Professional Development 🚀📖
Professor Shuanglin Qin is committed to continual professional advancement 🌟. As a principal investigator, he has led numerous high-impact projects under national and provincial funding programs, including the National Natural Science Foundation of China 💼🔬. He actively collaborates across disciplines to explore mechanisms of natural product-derived drugs. His editorial contributions span journals like the Journal of Oncology and Traditional Medicine Research 📝📊. As a peer reviewer for renowned scientific outlets, he ensures the integrity of research dissemination 🔍. His work fosters innovation in traditional Chinese medicine and strengthens links between academia and healthcare industries globally 🌍🧠.
Research Focus 🔍🤖
Professor Qin’s research primarily focuses on chemical biology and anti-cancer drug discovery 🧪🧬. He explores the molecular mechanisms of action and therapeutic potentials of natural products derived from traditional Chinese medicine 🌿💊. His interdisciplinary approach combines pharmacology, biochemistry, and medicinal chemistry to identify novel bioactive compounds targeting tumors 🎯. His efforts are directed toward developing precision medications with high efficacy and minimal side effects 🧠⚕️. By bridging modern technology with ancient remedies, his research significantly advances cancer therapeutics and natural product innovation 🔄🌱. His lab continues to pave the way in translational cancer research and drug development 🚀.
Awards and Honors 🏆🎖️
-
🥇 Winner, Hunan Science Fund for Distinguished Young Scholars
-
🏅 Winner, ChuTian Scholars Program, Hubei Province
-
📊 Principal Investigator, National Natural Science Foundation of China projects
-
🧪 Recipient, China Postdoctoral Science Foundation funding
-
📘 Recognized in Youth Talent Programs by Hubei Health Commission & Education Department
-
📝 Editorial roles in Journal of Oncology, Traditional Medicine Research, Life Research, and Medical Data Mining
-
🔍 Reviewer for journals like European Journal of Medicinal Chemistry and Frontiers in Cell and Developmental Biology
Publications & Citations 📚
-
📊 “Integrated evidence chain-based effectiveness evaluation of traditional Chinese medicines (Eff-iEC): A demonstration study” – Ye Luo et al., Acta Pharmaceutica Sinica B, 2025 | 📅 2025 | 📑 Cited by: 1
-
🧬 “PROTACs coupled with oligonucleotides to tackle the undruggable” – Guangshuai Zhang et al., Journal not specified, 2025 | 📅 2025 | 📑 Cited by: 0
-
🌿 “Exploring the mechanism of 6-Methoxydihydrosanguinarine in the treatment of lung adenocarcinoma based on network pharmacology, molecular docking and experimental investigation” – Xingyun Liu et al., BMC Complementary Medicine and Therapies, 2024 | 📅 2024 | 📑 Cited by: 2
-
🔬 “PROTAC technology: From drug development to probe technology for target deconvolution” – Si Yan et al., Journal not specified, 2025 | 📅 2025 | 📑 Cited by: 19
🔍 Conclusion:
Professor Qin’s dedication to translational cancer research, deep-rooted knowledge in natural product chemistry, and outstanding scientific contributions make him a model researcher in his domain. His influence spans innovation, education, and publication, fulfilling the highest standards for a Best Researcher Award recipient. He exemplifies not just academic productivity, but also real-world impact in advancing healthcare through traditional knowledge and modern science fusion.